EYPT insider buying and SEC filings, explained
EyePoint, Inc. · CIK 1314102
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Laboratory Analytical Instruments
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- EyePoint Pharmaceuticals, Inc.; pSivida Corp.; pSivida LTD
Insider activity in the last 12 months
Bought
$72K
Insiders who bought
2
Sold (not marked 10b5-1)
$942K
Planned sales (10b5-1)
$1.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 18, 2026 | Purchase (code P) | Karen L. Zaderej (Director) bought 10,600 shares at $4.93 ($52K), reported as a purchase (code P). Holdings up 28% to 49,100 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 18, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Ramiro Ribeiro (Chief Medical Officer) sold 4,875 shares at about $15.01 ($73K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 2, 2026 |
| Apr 17, 2026 | Planned (10b5-1) | Ramiro Ribeiro (Chief Medical Officer) sold 2,437 shares at $15.00 ($37K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Apr 20, 2026 |
| Mar 16, 2026 | Purchase (code P) | Jay S. Duker (CEO and Director) bought 1,500 shares indirectly (by trust) at $13.15 ($20K), reported as a purchase (code P). Holdings by trust up 2% to 100,665 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Ramiro Ribeiro (Chief Medical Officer) sold 2,438 shares at about $17.87 ($44K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Mar 5, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Ramiro Ribeiro (Chief Medical Officer) sold 2,437 shares at $15.00 ($37K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 18, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Ramiro Ribeiro (Chief Medical Officer) sold 42,544 shares at about $17.10 ($728K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 7, 2026 |
| Dec 4, 2025 | Sale | Bihua Chen (Former 10% Owner) sold 60,000 shares indirectly at about $15.70 ($942K). Indirect holdings down 1% to 8,265,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Dec 8, 2025 |
| Dec 4, 2025 | Planned (10b5-1) | Nancy Lurker (Director) sold 9,300 shares at about $15.11 ($141K), marked as a 10b5-1 plan trade. Holdings down 4% to 206,547 shares. | SEC filing Filed Dec 5, 2025 |
| Nov 26–28, 2025 | Planned (10b5-1) | Nancy Lurker (Director) sold 700 shares between Nov 26, 2025 and Nov 28, 2025 at about $14.95 ($10K), marked as a 10b5-1 plan trade. Holdings down <1% to 215,847 shares. | SEC filing Filed Dec 1, 2025 |
| Nov 11, 2025 | Planned (10b5-1) | Ramiro Ribeiro (Chief Medical Officer) sold 2,722 shares at about $11.61 ($32K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 12, 2025 |
25 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EYPT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.